02.20.2018
Prevent & Delay
$500,000.00
36 months
Targeting CAR-expressing regulatory T cells to pancreatic islets
Funds support a work into a preclinical proof-of-principle for an engineered targeted Treg cell therapy to treat type 1 diabetes.